4.7 Article

Predictors of PEG dependence after IMRT ± chemotherapy for oropharyngeal cancer

期刊

RADIOTHERAPY AND ONCOLOGY
卷 107, 期 3, 页码 300-304

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2013.05.021

关键词

IMRT; PEG tube; Dysphagia; Predictive models

向作者/读者索取更多资源

Purpose: To prospectively assess predictors of PEG dependence after IMRT with/without concomitant chemotherapy (CHT). Methods and materials: One-hundred-seventy-one patients were considered (exclusive RT: 58, RT+CHT: 113; 159/171 treated at a median dose of 70 Gy, 2 Gy/fr). Patients treated with RT+CHT underwent prophylactic PEG insertion; PEG was as needed for the others. A number of clinical factors and dose-volume information concerning oral mucosa (OM), constrictors, masticatory muscles, larynx, esophagus and parotids were available. The 25th/10th percentiles of the duration of PEG dependence were our end-points (respectively 3.3 and 7 months, PEG3/PEG7). Logistic uni and multi-variate (MVA) analyses were performed. Results: Concerning PEG3, the independent predictors at MVA were: CHT/PEG policy (OR: 6.8, p = 0.001), V9.5G_OM Gy/week (OR: 1.017, p = 0.01), larynx V50 (OR: 1.018, p = 0.01) and superior constrictor (SC) D_mean (OR: 1.002, p = 0.005); the predictive value of the model (AUC) was 0.818 (95% CI: 0.751-0.873). The independent predictors of PEG7 were: larynx V50 (OR: 1.042, p = 0.0005) and SC D_mean (OR: 1.003, p = 0.02), symptoms at diagnosis (yes vs no, OR: 3.6, p = 0.08) and sex (male vs female, OR: 0.25, p = 0.07); AUC was 0.897 (95% CI: 0.841-0.939). Conclusions: OM V9.5 Gy/week and CHT/PEG_policy modulate the risk of early PEG dependence. For longer PEG dependence, larynx V50 (or D_mean) and SC D_mean are highly predictive, suggesting that the fibrosis of constrictors and larynx is the main cause. (c) 2013 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center

Richard C. Cardoso, Mona Kamal, Jhankruti Zaveri, Mark S. Chambers, G. Brandon Gunn, Clifton D. Fuller, Stephen Y. Lai, Frank E. Mott, Holly McMillan, Katherine A. Hutcheson

Summary: The study found a 31% prevalence of self-reported trismus, with severity correlating with quality of life and dysphagia. Trismus severity was negatively associated with T-stage, nodal stage, tumor sub-site, and concurrent chemoradiation.

SUPPORTIVE CARE IN CANCER (2021)

Review Oncology

Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy

Nicolette Taku, Li Wang, Adam S. Garden, David I. Rosenthal, G. Brandon Gunn, William H. Morrison, C. David Fuller, Jack Phan, Jay P. Reddy, Amy C. Moreno, Michael T. Spiotto, Gregory Chronowski, Shalin J. Shah, Lauren L. Mayo, Neil D. Gross, Renata Ferrarotto, X. Ronald Zhu, Xiaodong Zhang, Steven J. Frank

Summary: The rise in HPV-associated OPC, diagnosed at a young age with a good prognosis, has led to the need for treatment techniques like IMPT, which reduce side effects. Preclinical studies show that HPV-positive squamous cell carcinoma is more sensitive to proton radiation. Retrospective studies suggest that IMPT has lower rates of side effects compared to intensity-modulated photon radiotherapy. Two phase III trials are expected to provide evidence on the effectiveness of IMPT for these patients.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)

Article Otorhinolaryngology

Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study

Kevin Diao, Theresa P. Nguyen, Amy C. Moreno, Jay P. Reddy, Adam S. Garden, Catherine H. Wang, Samuel Tung, Congjun Wang, Xin A. Wang, David Rosenthal, Clifton D. Fuller, Gary B. Gunn, Steven J. Frank, William H. Morrison, Shalin J. Shah, Anna Lee, Michael T. Spiotto, Shirley Y. Su, Renata Ferrarotto, Jack Phan

Summary: The study observed a median overall survival of 44.3 months for patients receiving SBRT retreatment for recurrent head and neck cancers. Systemic therapy had a positive impact on improving regional and distant control, while toxicities were influenced by anatomic site and systemic therapy.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy

Fabiana Gregucci, Alba Fiorentino, Rosario Mazzola, Francesco Ricchetti, Ilaria Bonaparte, Alessia Surgo, Vanessa Figlia, Roberta Carbonara, Morena Caliandro, Maria Paola Ciliberti, Ruggero Ruggieri, Filippo Alongi

Summary: The study aimed to evaluate the ability of contrast-enhanced CT image-based radiomic analysis in predicting local response in pancreatic cancer patients treated with SBRT. The analysis identified GLCM25_Correlation and NID25_Busyness as independent predictive variables for LR, with promising predictive value. The findings suggest the potential for a more personalized approach to SBRT in different patient subgroups.

RADIOLOGIA MEDICA (2022)

Article Oncology

Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients

Luca Nicosia, Vanessa Figlia, Nicola Ricottone, Francesco Cuccia, Rosario Mazzola, Niccolo Giaj-Levra, Francesco Ricchetti, Michele Rigo, Fatemeh Jafari, Stefano Maria Magrini, Andrea Girlando, Filippo Alongi

Summary: This study aims to demonstrate the effectiveness of stereotactic body radiotherapy (SBRT) in delaying the switch to a subsequent systemic treatment in patients with oligoprogressive breast cancer. The results show that SBRT can delay the progression of treatment, but patient selection is necessary, and several predictive factors for individualized treatment have been identified.

CLINICAL & EXPERIMENTAL METASTASIS (2022)

Article Oncology

Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors

Francesco Cuccia, Rosario Mazzola, Vanessa Figlia, Niccolo Giaj-Levra, Luca Nicosia, Francesco Ricchetti, Michele Rigo, Giorgio Attina, Claudio Vitale, Edoardo Pastorello, Ruggero Ruggieri, Filippo Alongi

Summary: This study reports the retrospective data of patients who received stereotactic body radiotherapy for pulmonary oligometastases. The results suggest that SBRT is a feasible and effective treatment option with favorable outcomes and low toxicity. Sequential oligometastases patients have a higher survival advantage, and local control is associated with improved progression-free survival rates.

STRAHLENTHERAPIE UND ONKOLOGIE (2022)

Article Oncology

1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes

Francesco Cuccia, Michele Rigo, Vanessa Figlia, Niccolo Giaj-Levra, Rosario Mazzola, Luca Nicosia, Francesco Ricchetti, Giovanna Trapani, Antonio De Simone, Davide Gurrera, Stefania Naccarato, Gianluisa Sicignano, Ruggero Ruggieri, Filippo Alongi

Summary: This study reports the preliminary data of using 1.5T MR-Linacs for prostate or prostate bed re-irradiation. The study found that this treatment option has minimal toxicity and encouraging clinical outcomes.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac

Stefania Naccarato, Michele Rigo, Roberto Pellegrini, Peter Voet, Hafid Akhiat, Davide Gurrera, Antonio De Simone, Gianluisa Sicignano, Rosario Mazzola, Vanessa Figlia, Francesco Ricchetti, Luca Nicosia, Niccolo Giaj-Levra, Francesco Cuccia, Nadejda Stavreva, Dobromir S. Pressyanov, Pavel Stavrev, Filippo Alongi, Ruggero Ruggieri

Summary: This study compared the adaptive planning and manual planning for SBRT treatment of prostate cancer. The study found that the automated planning (mCycle) performed better than manual planning in terms of target dose coverage and rectal dose sparing on the 1.5T MR-Linac. However, mCycle plans consumed slightly more delivery time and monitor units. This study provides a feasible solution for adaptive planning on the 1.5T MR-Linac.

ADVANCES IN RADIATION ONCOLOGY (2022)

Article Medicine, General & Internal

1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer

Luca Nicosia, Giovanna Trapani, Michele Rigo, Matilde Fiorini, Niccolo Giaj-Levra, Rosario Mazzola, Edoardo Pastorello, Francesco Ricchetti, Filippo Alongi, Francesco Cuccia, Vanessa Figlia

Summary: This study evaluated the efficacy and toxicity of daily adaptive MR-guided SBRT on a 1.5 T MR-linac for treating lymph node oligometastases from PCa. The results showed that lymph node SBRT on a 1.5 T MR-linac provides high local control rates with an excellent toxicity profile.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Health Care Sciences & Services

1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients

Filippo Alongi, Michele Rigo, Vanessa Figlia, Luca Nicosia, Rosario Mazzola, Niccolo Giaj Levra, Francesco Ricchetti, Giovanna Trapani, Giorgio Attina, Claudio Vitale, Edoardo Pastorello, Antonio De Simone, Davide Gurrera, Stefania Naccarato, Gianluisa Sicignano, Ruggero Ruggieri, Francesco Cuccia

Summary: This study reports the preliminary outcomes of adverse events and quality of life in the first 100 patients treated with 1.5T MR-guided stereotactic body radiotherapy for prostate cancer. The results show that the treatment had minimal acute toxicity and improved the quality of life for patients.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Oncology

PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer

Edoardo Pastorello, Luca Nicosia, Francesco Cuccia, Laura Olivari, Matilde Fiorini, Niccolo Giaj Levra, Rosario Mazzola, Francesco Ricchetti, Michele Rigo, Paolo Ravelli, Salvatore D'Alessandro, Matteo Salgarello, Ruggero Ruggieri, Filippo Alongi

Summary: This study evaluated the efficacy, toxicity, and pattern of relapse in SBRT delivered to non-spinal-bone metastases from prostate cancer. The results showed that SBRT is a safe and effective tool for the local progression-free survival in primary bone lesions, and intraosseous relapse was a relatively rare event.

CANCERS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy

Luca Nicosia, Rosario Mazzola, Claudio Vitale, Francesco Cuccia, Vanessa Figlia, Niccolo Giaj-Levra, Francesco Ricchetti, Michele Rigo, Ruggiero Ruggeri, Stefano Cavalleri, Filippo Alongi

Summary: This study evaluated the impact of moderately hypofractionated postoperative radiotherapy on prostate cancer. The findings showed that this treatment approach achieved acceptable disease control rate without increasing or causing unexpected toxicity. Gleason score and hormone therapy were found to be associated with disease progression and biochemical relapse.

RADIOLOGIA MEDICA (2022)

Article Oncology

Factors associated with complex oral treatment device usage in patients with head and neck cancer

Stephen Palasi, Ning Zhang, Mikaela Bankston, Joy Godby, Hannah Burrows, Jennifer Lagunas, William Perkison, Brandon Gunn, Mark S. Chambers, David Rosenthal, William Morrison, Adam Garden, Clifton David Fuller, Sharon Giordano, Eugene J. Koay

Summary: The purpose of this study was to identify clinical and epidemiological factors associated with the utilization of a complex oral treatment device for head and neck cancer patients undergoing radiation therapy. Retrospective analysis of data from the SEER-Medicare databases revealed that age, gender, and geographical disparities were linked to the utilization of the device. Further research and development are needed to improve availability and increase utilization among specific patient populations.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)

Article Oncology

Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life

Alexander D. Sherry, Dario Pasalic, G. Brandon Gunn, C. David Fuller, Jack Phan, David Rosenthal, William H. Morrison, Erich M. Sturgis, Neil D. Gross, Maura L. Gillison, Renata Ferrarotto, Adel K. El-Naggar, Adam S. Garden, Steven J. Frank

Summary: PRT for HNCUP was associated with highly favorable dosimetric and clinical outcomes, including minimal oral mucositis, xerostomia, and dysphagia. Toxicity and QOL may be superior with PRT compared with conventional radiation therapy and PRT maintains equivalent oncologic control.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Article Oncology

Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer

Grace L. Smith, Shuangshuang Fu, Matthew S. Ning, Diem-Khanh Nguyen, Paul M. Busse, Robert L. Foote, Adam S. Garden, Gary B. Gunn, Clifton D. Fuller, William H. Morrison, Gregory M. Chronowski, Shalin J. Shah, Lauren L. Mayo, Jack Phan, Jay P. Reddy, James W. Snider, Samir H. Patel, Sanford R. Katz, Alexander Lin, Nasiruddin Mohammed, Roi Dagan, Nancy Y. Lee, David Rosenthal, Steven J. Frank

Summary: This study compared work outcomes in patients with oropharyngeal cancer receiving intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for chemoradiation therapy. The results showed that patients treated with IMPT demonstrated better trends in recovery.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)